StressGen Biotechnologies Corp. of Victoria, British Columbia,this month returned to the private-placement well for $3million to $5 million in new money, primarily from theCanadian venture capital community.
Richard M. Glickman, StressGen's founder and president, toldBioWorld he hopes to bank this second-round package byspring. He is "actively looking for environmental investors," butwill develop cellular stress response proteins primarily formedical applications.
Glickman and two U.S. scientists founded the company in April1990, with seed funding of $1.2 million from Trianon Equitiesand Discovery Enterprises, of Vancouver. The company hasorganized "StressNet," involving some 250 stress-responseresearchers in 26 countries.
"We are the world's largest supplier of research reagents forheat shock proteins," he said, "including DNA probes, purifiedproteins and some 16 monoclonal antibodies, targeting mostmajor classes of stress families." -- David N. Leff
(c) 1997 American Health Consultants. All rights reserved.